Emivirine

Emivirine
Names
	Preferred IUPAC name 6-Benzyl-1-(ethoxymethyl)-5-(propan-2-yl)pyrimidine-2,4(1H,3H)-dione
	Other names MKC-442
Identifiers
CAS Number	149950-60-7 ;
3D model (JSmol)	Interactive image;
ChEMBL	ChEMBL35033 ;
ChemSpider	58529 ;
PubChem CID	65013;
UNII	X87G8IX72O ;
CompTox Dashboard (EPA)	DTXSID80164437 ;
	InChI InChI=1S/C17H22N2O3/c1-4-22-11-19-14(10-13-8-6-5-7-9-13)15(12(2)3)16(20)18-17(19)21/h5-9,12H,4,10-11H2,1-3H3,(H,18,20,21) Key: MLILORUFDVLTSP-UHFFFAOYSA-N ; InChI=1/C17H22N2O3/c1-4-22-11-19-14(10-13-8-6-5-7-9-13)15(12(2)3)16(20)18-17(19)21/h5-9,12H,4,10-11H2,1-3H3,(H,18,20,21) Key: MLILORUFDVLTSP-UHFFFAOYAG;
	SMILES CCOCN1C(=C(C(=O)NC1=O)C(C)C)CC2=CC=CC=C2;
Properties
Chemical formula	C17H22N2O3
Molar mass	302.374 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). verify (what is ?) Infobox references

Emivirine (MKC-442) is a failed experimental agent for the treatment of HIV. It is a non-nucleoside reverse transcriptase inhibitor.^[1] While emivirine showed promising antiviral activity in vitro, it failed to show sufficient efficacy in human trials. However it is still notable as an early proof of concept, which led to the discovery of a number of related antiviral drugs.^[2]

References

^ CID 65013 from PubChem
^ Serge Van Calenbergh & Piet Herdewijn (February 25, 2005). "A heterogeneous collection of novel antiviral pyrimidines". Expert Opinion on Therapeutic Patents. 10 (3): 289–295. doi:10.1517/13543776.10.3.289.

[1] CID 65013 from PubChem

[2] Serge Van Calenbergh & Piet Herdewijn (February 25, 2005). "A heterogeneous collection of novel antiviral pyrimidines". Expert Opinion on Therapeutic Patents. 10 (3): 289–295. doi:10.1517/13543776.10.3.289.

[1]

[2]